Stem Cells therapy

ما هو نوع الخلايا الجذعية المستخدمة للعلاج في أوكرانيا؟

هل هناك ضمان التحسن من العلاج ؟  وماهي نسبة التحسن ؟ ماهو مصدر الخلايا الجذعية؟ شكرا يكون التحسن بعد العلاج بالخلايا الجذعية موجودًا دائمًا. تتوقف درجة التحسن ودرجة التحسن على المريض وتكون دائمًا فردية. يبدأ Read more…

By NBScience, ago
Stem Cells therapy

Psychiatry 2018

Psychiatry 2018 Kiev,Ukraine medical meeting Date: 25 October 2018 (deadline – June 20, 2018)   Conference main topics: 1) antipsychotic treatment 2) schizophrenia, bipolar  disorder treatment 3) antidepressant medication PROGRAMME 25 October 2018 11.00-12.00 Clinic visit 12.15-13.00 Read more…

By NBScience, ago
Stem Cells therapy

CHA2DS2-VASC score

CHA2DS2-VASC score CHADS2 and CHA2DS2-VASc Score for Stroke Risk Assessment in Atrial Fibrillation Score CHA2DS2-VASc Risk Criteria 1 point Hypertension 2 points Age ≥75 years 1 point Diabetes mellitus 2 points Stroke/Transient Ischemic Attack/Thromboembolic event Read more…

By NBScience, ago
Stem Cells therapy

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. Mesenchymal stem cells (MSCs) are under evaluation as a therapy for ischemic Read more…

By NBScience, ago
Stem Cells therapy

Pediatrics – 2015

Pediatrics- 2015 medical conference  Dates: October 08-09, 2015 Venue: Ambassador plaza hotel  5/1 Marshal Grechko Str. Kyiv 04136 Ukraine Main topics: conference offering a comprehensive review of selected pediatric topics: infectious diseases, emergency medicine, orthopedics, Read more…

By NBScience, ago
Stem Cells therapy

HAS-BLED score

HAS-BLED score Condition Points  H  Hypertension: (uncontrolled, >160 mmHg systolic) 1  A  Abnormal renal function: Dialysis, transplant, Cr >2.26 mg/dL or >200 µmol/LAbnormal liver function: Cirrhosis or Bilirubin >2x Normal or AST/ALT/AP >3x Normal 1 1 Read more…

By NBScience, ago
stem cell therapy